The study of early application with Dixiong Decoction (地芎汤) for non-small cell lung cancer to decrease the incidence and severity of radiation pneumonitis: A prospective, randomized clinical trial

Yong-qi Dou; Ming-hui Yang; Zheng-mao Wei; Chun Xiao; Xu-hui Yang

doi:10.1007/s11655-010-9998-x

Your Location：

Home >

Browse articles >

The study of early application with Dixiong Decoction (地芎汤) for non-small cell lung cancer to decrease the incidence and severity of radiation pneumonitis: A prospective, randomized clinical trial

OriginalPaper | Updated：2021-08-27

- The study of early application with Dixiong Decoction (地芎汤) for non-small cell lung cancer to decrease the incidence and severity of radiation pneumonitis: A prospective, randomized clinical trial
- The study of early application with Dixiong Decoction (地芎汤) for non-small cell lung cancer to decrease the incidence and severity of radiation pneumonitis: A prospective, randomized clinical trial
- 中国结合医学杂志（英文版） 2010年16卷第5期页码：411-416
- Affiliations：
  
  Chinese Medicine Institute of PLA General Hospital,Beijing,China
- Author bio：
- Funds：
  
  Supported by the National Natural Science Foundation of China (No. 30371826)
- DOI：10.1007/s11655-010-9998-x
  中图分类号：
- 纸质出版日期：2010，
  
  网络出版日期：2010-6-10，
Scan for full text
Dou, Yq., Yang, Mh., Wei, Zm. et al. The study of early application with Dixiong Decoction (地芎汤) for non-small cell lung cancer to decrease the incidence and severity of radiation pneumonitis: A prospective, randomized clinical trial., Chin. J. Integr. Med. 16, 411–416 (2010). https://doi.org/10.1007/s11655-010-9998-x

Yong-qi Dou, Ming-hui Yang, Zheng-mao Wei, et al. The study of early application with Dixiong Decoction (地芎汤) for non-small cell lung cancer to decrease the incidence and severity of radiation pneumonitis: A prospective, randomized clinical trial[J]. Chinese Journal of Integrative Medicine, 2010,16(5):411-416.
Dou, Yq., Yang, Mh., Wei, Zm. et al. The study of early application with Dixiong Decoction (地芎汤) for non-small cell lung cancer to decrease the incidence and severity of radiation pneumonitis: A prospective, randomized clinical trial., Chin. J. Integr. Med. 16, 411–416 (2010). https://doi.org/10.1007/s11655-010-9998-x DOI：

Yong-qi Dou, Ming-hui Yang, Zheng-mao Wei, et al. The study of early application with Dixiong Decoction (地芎汤) for non-small cell lung cancer to decrease the incidence and severity of radiation pneumonitis: A prospective, randomized clinical trial[J]. Chinese Journal of Integrative Medicine, 2010,16(5):411-416. DOI： 10.1007/s11655-010-9998-x.

摘要

To evaluate the efficacy of compound Dixiong Decoction (地芎汤

a Chinese herbal decoction) on early prevention of radiation pneumonitis. Forty-six patients with non-small cell lung cancer who were planning to receive radiotherapy were randomly assigned to the treatment group treated with the compound Dixiong Decoction and the control group treated with a commonly used herbal decoction which has the effects of supplementing qi and nourishing yin

clearing heat and detoxifying at the time of radiotherapy. Primary measure was the incidence of radiation pneumonitis after radiotherapy. Secondary outcomes included Watters clinical radiographic physiologic (CRP) dyspnea score

the Radiation Therapy Oncology Group (RTOG) grading score

Karnofsky Performance Status (KPS) score

and the application of corticosteroids. The incidence of radiation pneumonitis in the treatment group was 10.0%

while that in the control group was 26.3% (P=0.0032). The Watters CRP dyspnea score and RTOG grading score in the treatment group were significantly =lower than those in the control group (P<0.05). The KPS score in the treatment group was significantly higher than that in the control group (P<0.01). The dosage of corticosteroids was smaller with a shorter duration of therapy in the treatment group than that in the control group. The early application of the Chinese herbal decoction compound Dixiong Decoction can decrease the incidence of radiation pneumonitis

reduce the injury of the lung

and improve the life quality of the patients.

Abstract

To evaluate the efficacy of compound Dixiong Decoction (地芎汤

the Radiation Therapy Oncology Group (RTOG) grading score

Karnofsky Performance Status (KPS) score

and the application of corticosteroids. The incidence of radiation pneumonitis in the treatment group was 10.0%

reduce the injury of the lung

and improve the life quality of the patients.

关键词

radiation pneumonitiscomplementary and alternative medicineChinese Herbal Medicineclinical trial

Keywords

radiation pneumonitiscomplementary and alternative medicineChinese Herbal Medicineclinical trial

references

Dörr W, Baumann M, Herrmann T. Radiation-induced lung damage: a challenge for radiation biology, experimental and clinical radiotherapy. Int J Radiat Biol 2000;76:443–446.

Monson JM, Stark P, Reilly JJ, Sugarbaker DJ, Strauss GM, Swanson SJ, et al. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer 1998;82:842–850.

Novakova-Jiresova A, van Gameren MM, Coppes RP, Kampinga HH, Groen HJ. Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients. Radiother Oncol 2004;71:183–189.

Onishi H, Kuriyama K, Yamaguchi M, Komiyama T, Tanaka S, Araki T, et al. Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis. Lung Cancer 2003;40:79–84.

Ghafoori P, Marks LB, Vujaskovic Z, Kelsey CR. Radiation-induced lung injury. Assessment, management, and prevention. Oncology (Williston Park) 2008;22:37–47. discussion 52–53.

Ataya S, Elwing J, Biddinger P, Panos RJ. Radiation-induced lung injury. Clin Pulm Med 2006;13:232–242.

Liu L, Ding Q, Dai XF, Zhao YX, Ke Y, Wu G. Study on the controlling effect of Shenqi Fuzheng Injection on plasma cytokine network in patients with thoracic tumor undergoing radiotherapy. Chin J Integr Tradit West Med (Chin) 2007;27:1082–1085.

Zheng W, Gao ZH, Wu LN, Tian X. Clinical observation on treatment of radiative pneumonia in patients with lung cancer by integrative Chinese and Western medicine. Chin J Integr Tradit West Med (Chin) 2007;27:1121–1123.

Yang MH, Dou YQ, Zang Q, Feng LC, Liu Y. Effects of blood-cooling and promoting drugs on rats with radiation-induced lung injury. Chin J Integr Tradit West Med (Chin) 2007;27:827–831.

Watters LC, King TE, Schwarz MI, Waldron JA, Stanford RE, Cherniack RM. A clinical radiographic and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986;133:97–103.

Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341–1346.

Novakova-Jiresova A, van-Luijk P, van-Goor H, Kampinga H, Coppes R. Changes in expression of injury after irradiation of increasing volumes in rat lung. Int J Radiat Oncol Biol Phys 2007;67:1510–1518.

Fleckenstein K, Zgonjanin L, Chen L, Rabbani Z, Jackson IL, Thrasher B, et al. Temporal onset of hypoxia and oxidative stress after pulmonary irradiation. Int J Radiat Oncol Biol Phys 2007;68:196–204.

Rube CE, Uthe D, Schmid KW, Richter KD, Wessel J, Schuck A, et al. Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation. Int J Radiat Oncol Biol Phys 2000;47:1033–1042.

Hartsell WF, Scott CB, Dundas GS, Mohiuddin M, Meredith RF, Rubin P, et al. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03. Am J Clin Oncol 2007;30:368–763.

Chen Y, Hyrien O, Williams J, Okunieff P, Smudzin PT, Rubin P. Interleukin (IL)-1A and IL-6: applications to the predictive diagnostic testing of radiation pneumonitis. Int J Radiat Oncol Biol Phys 2005;62:260–266.

FULL TEXT LINK

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Effects and mechanisms of actions of Chinese herbal medicines for asthma

The model of western integrative medicine: The role of Chinese medicine

Effect of chinese traditional healthcare exercises on 136 junior school students

Review of the regulations for clinical research in herbal medicines in USA